We’re on a mission to help branded retail and specialty-lite therapies achieve their full #PatientAccess potential. See the PhilRx platform in action:
Phil, Inc.
Pharmaceutical Manufacturing
San Francisco, CA 27,489 followers
Medication Access, Simplified. We are on a mission to help patients get their medications quickly, easily and affordably
About us
PHIL helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support. Streamline your medication access journey with the PhilRx Digital Hub. Our platform integrates with a national dispense network to deliver a seamless access experience that provides brand teams with full visibility into the drug channel. Improve patient access and adherence, boost provider engagement, maximize covered dispenses, and drive gross-to-net with PHIL. Discover how we can help your brands reach their commercial potential at www.phil.us.
- Website
-
http://phil.us
External link for Phil, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Patient Access, Channel Strategy, Distribution Network, Provider Engagement, Field Team Enablement, and Digital Hub
Locations
-
Primary
Get directions
San Francisco, CA 94111, US
Employees at Phil, Inc.
-
Jeff Richards
Managing Partner at Notable Capital
-
Thomas Luby
Commercial Strategy Leader | BioPharma & Health Tech | Scaled B2B Revenue 50x | Patient Access, Affordability, Reimbursement | SVP / CRO / Advisor
-
Deepak Thomas
Founder/CEO at Phil, Inc.
-
Dhananjay Ramaswamy
VP of Product Management at Phil, Inc.
Updates
-
"AI marks a new inflection point—one that can reimagine patient care at unprecedented scale." - Deepak Thomas, CEO & Founder of Phil, Inc. We're thrilled to announce that we have secured $60M in capital from K2 HealthVentures to accelerate #AI integration across our pharmaceutical commercialization platform. This milestone marks an extraordinary step forward in our mission to modernize #MedicationAccess in specialty-lite and retail, and enhance the healthcare experience for patients, providers, and pharma. Read the press release: https://lnkd.in/gGx3NwAS
-
We're headed to Informa's #AccessUSA Conference in March! Our team is excited to connect and discuss the latest in #DigitalHubs for driving patient outcomes and commercial success. Join our team onsite - Renee Kasun, Chris Sweitzer, Prince Anyanwu: https://lnkd.in/gTsTkiiX
-
-
What a session! It was a privilege to have Bruce Phelan from Blue Fin Group, an IntegriChain Company, share his insights alongside Thomas Luby in our recent webinar on overcoming #Access barriers in retail and specialty lite. Check out the video below for a sneak peek of what you'll learn - watch the full webinar on demand: https://hubs.la/Q037nWx50
-
Discover the new KPIs for measuring and managing #GrossToNet - check out Thomas Luby's insights featured in #DrugChannels! Read the article: https://lnkd.in/ge6pi9ye
From Phil, Inc.: From Data Gaps to Revenue Gains: Harnessing the Power of Comprehensive Data to Drive GTN Watch PHIL’s free on-demand webinar "Four Patient Access Barriers to Address for High-Impact Programs": https://drugch.nl/4k092Ks Read the article: https://drugch.nl/437fbP9 #sponsored
-
-
Calling all #Access and #PatientSupport leaders! This insight-packed webinar dives into solving today's biggest barriers to medication access. Don't miss out on the opportunity to get your questions answered from incredible speakers - Bruce Phelan from Blue Fin Group, an IntegriChain Company, and Phil, Inc.'s very own, Thomas Luby. Save your spot: https://hubs.la/Q035Fs3f0
-
-
Solving access challenges is key to the success of your #PatientSupport programs. If you’re looking tackle these hurdles head-on, join our upcoming webinar on February 18 to learn about: ✔️ Overcoming today's biggest barriers to medication access ✔️ Elevating your patient support programs across core areas ✔️ Leveraging best practices and success stories from top brands You'll hear from Phil, Inc.'s SVP Business Development, Thomas Luby and Blue Fin Group, an IntegriChain Company's Partner, Bruce Phelan. ➡️ Save your spot: https://hubs.la/Q035Fs3f0
-
-
We're rounding off the week with a new #EmployeeSpotlight, featuring Robert Schumaker! Bob champions a collaborative, patient-centric approach to creating a strong partner ecosystem at PHIL. Over the past five years, he’s been pivotal in building and scaling our partnership operations with a focus on making an meaningful impact on patients’ lives. Read Bob's spotlight: https://lnkd.in/gpQqhQBU
-
-
#PatientEngagement is a critical factor for brand success. In this blog, you'll gain insight into the top initiatives #Pharma brands are leveraging to strengthen your program outcomes. Read blog: https://lnkd.in/gbTiW3Ru
-
Stay competitive in the ever-changing access landscape - here are eight #PatientAccess trends to keep top of mind in 2025. Read blog: https://lnkd.in/gNqqUG7U